How Effective have the FDA’s Warnings on Urogynecologic Mesh Been?

This article will detail the relative effectiveness of warnings issued by the FDA regarding Urogynecologic mesh use. According to the article, An Appraisal of the Food and Drug Administration Warning on Urogynecologic Surgical Mesh, published in Current Urology Reports (2012, 13:231-239) manufacturers market surgical mesh kits with a goal of increasing speed and ease of placement. The FDA reports over the past few years have sought to increase the awareness of the potential risks of surgical mesh when used in a transvaginal surgical procedure despite manufacturer’s claims.

More and more often reports are coming out which emphasize the fact that surgeons who use these mesh kits must have specialized training which enables them to “recognize and manage the complications of surgical mesh implants.” Governmental regulation of these mesh devices has also come under fire; while there are many different agencies in charge of regulation and reporting, women have nevertheless been harmed by transvaginally placed mesh implants. 

Corrective Surgical Procedures for Apical Prolapse

This article will discuss the various surgical procedures currently used in the treatment of apical prolapse. Apical prolapse is the descent of uterus, cervix or vaginal vault and affects millions of women worldwide. By the age of 80 to 85 years, as many as 19 percent of women will have undergone a surgical procedure to correct pelvic organ prolapse or stress urinary incontinence.

According to an article in the Obstetrics and Gynecology Board Review Manual titled Diagnosis and Treatment of Vaginal Apical Prolapse, “As the average life span of the population increases, problems related to pelvic support defects are seen with increasing frequency in women.”